neuropathic cancer pain
Conditions
Interventions
Study group:The study group received a modified Huangqi Guizhi Wuwu Decoction for external application combined with oral pregabalin.
Control:oral pregabalin
Sponsors
Liangping District People's Hospital of Chongqing
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1) Age between 20 and 70 years; 2) Pathologically confirmed diagnosis of malignant tumor; 3) Definitive diagnosis of NCP; 4) Pain level classified as mild to moderate; 5) Expected survival time of more than 2 months; 6) Performance status score (ECOG-PS) of 0–1; 7) No cognitive impairment, able to accurately understand the content of the questionnaire; 8) Aware of own condition and has signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1) History of mental illness; 2) Presence of consciousness or communication disturbances; 3) Concurrent severe acute or chronic diseases; 4) Neuropathic pain caused by other diseases; 5) Presence of skin infection with rupture; 6) Mental illness, depression, or untreated thyroid dysfunction; 7) Patients with skin allergies to external traditional Chinese medicine applications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| numerical rating scal scores;Pain Treatment Response; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life Questionnaire-C30;Traditional Chinese medicine symptom scores; | — |
Countries
China
Contacts
Public ContactZe-Gang Chen
Liangping District People's Hospital of Chongqing
Outcome results
None listed